Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Novel molecular changes induced by Nrg1 hypomorphism and Nrg1-cannabinoid interaction in adolescence: a hippocampal proteomic study in mice.

Spencer JR, Darbyshire KM, Boucher AA, Kashem MA, Long LE, McGregor IS, Karl T, Arnold JC.

Front Cell Neurosci. 2013 Feb 26;7:15. doi: 10.3389/fncel.2013.00015.

2.

Heterozygous neuregulin 1 mice display greater baseline and Delta(9)-tetrahydrocannabinol-induced c-Fos expression.

Boucher AA, Hunt GE, Karl T, Micheau J, McGregor IS, Arnold JC.

Neuroscience. 2007 Nov 23;149(4):861-70.

PMID:
17905522
3.

Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice.

Long LE, Chesworth R, Huang XF, Wong A, Spiro A, McGregor IS, Arnold JC, Karl T.

PLoS One. 2012;7(4):e34129. doi: 10.1371/journal.pone.0034129.

4.

Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Delta9-tetrahydrocannabinol.

Boucher AA, Arnold JC, Duffy L, Schofield PR, Micheau J, Karl T.

Psychopharmacology (Berl). 2007 Jun;192(3):325-36.

PMID:
17333138
5.

Transmembrane domain Nrg1 mutant mice show altered susceptibility to the neurobehavioural actions of repeated THC exposure in adolescence.

Long LE, Chesworth R, Huang XF, McGregor IS, Arnold JC, Karl T.

Int J Neuropsychopharmacol. 2013 Feb;16(1):163-75. doi: 10.1017/S1461145711001854.

PMID:
22226049
6.

A follow-up study: acute behavioural effects of Delta(9)-THC in female heterozygous neuregulin 1 transmembrane domain mutant mice.

Long LE, Chesworth R, Arnold JC, Karl T.

Psychopharmacology (Berl). 2010 Aug;211(3):277-89. doi: 10.1007/s00213-010-1896-6.

PMID:
20571781
7.

A neuregulin 1 transmembrane domain mutation causes imbalanced glutamatergic and dopaminergic receptor expression in mice.

Newell KA, Karl T, Huang XF.

Neuroscience. 2013 Sep 17;248:670-80. doi: 10.1016/j.neuroscience.2013.06.037.

PMID:
23811072
8.

Female neuregulin 1 heterozygous mice require repeated exposure to Δ⁹-tetrahydrocannabinol to alter sensorimotor gating function.

Spencer JR, Chohan TW, Karl T, Arnold JC.

Pharmacopsychiatry. 2013 Nov;46(7):286-91. doi: 10.1055/s-0033-1355390.

PMID:
24105081
9.

Neuregulin 1 expression and electrophysiological abnormalities in the Neuregulin 1 transmembrane domain heterozygous mutant mouse.

Long LE, Anderson P, Frank E, Shaw A, Liu S, Huang XF, Pinault D, Karl T, O'Brien TJ, Shannon Weickert C, Jones NC.

PLoS One. 2015 May 19;10(5):e0124114. doi: 10.1371/journal.pone.0124114.

10.

Partial genetic deletion of neuregulin 1 and adolescent stress interact to alter NMDA receptor binding in the medial prefrontal cortex.

Chohan TW, Nguyen A, Todd SM, Bennett MR, Callaghan P, Arnold JC.

Front Behav Neurosci. 2014 Sep 29;8:298. doi: 10.3389/fnbeh.2014.00298.

11.

Partial genetic deletion of neuregulin 1 modulates the effects of stress on sensorimotor gating, dendritic morphology, and HPA axis activity in adolescent mice.

Chohan TW, Boucher AA, Spencer JR, Kassem MS, Hamdi AA, Karl T, Fok SY, Bennett MR, Arnold JC.

Schizophr Bull. 2014 Nov;40(6):1272-84. doi: 10.1093/schbul/sbt193.

12.

The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids.

Boucher AA, Hunt GE, Micheau J, Huang X, McGregor IS, Karl T, Arnold JC.

Int J Neuropsychopharmacol. 2011 Jun;14(5):631-43. doi: 10.1017/S146114571000091X.

PMID:
20701826
13.

Adolescent neuregulin 1 heterozygous mice display enhanced behavioural sensitivity to methamphetamine.

Spencer JR, Darbyshire KM, Boucher AA, Arnold JC.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Dec 3;39(2):376-81. doi: 10.1016/j.pnpbp.2012.07.014.

PMID:
22850204
14.

Endocannabinoid dysregulation in cognitive and stress-related brain regions in the Nrg1 mouse model of schizophrenia.

Clarke DJ, Stuart J, McGregor IS, Arnold JC.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jan 4;72:9-15. doi: 10.1016/j.pnpbp.2016.08.006.

PMID:
27521758
15.

Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1+/- knock-outs compared with wild-type mice.

Bjarnadottir M, Misner DL, Haverfield-Gross S, Bruun S, Helgason VG, Stefansson H, Sigmundsson A, Firth DR, Nielsen B, Stefansdottir R, Novak TJ, Stefansson K, Gurney ME, Andresson T.

J Neurosci. 2007 Apr 25;27(17):4519-29.

16.

Differential role of the nitric oxide pathway on delta(9)-THC-induced central nervous system effects in the mouse.

Azad SC, Marsicano G, Eberlein I, Putzke J, Zieglgänsberger W, Spanagel R, Lutz B.

Eur J Neurosci. 2001 Feb;13(3):561-8.

PMID:
11168564
17.

Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia.

Hahn CG, Wang HY, Cho DS, Talbot K, Gur RE, Berrettini WH, Bakshi K, Kamins J, Borgmann-Winter KE, Siegel SJ, Gallop RJ, Arnold SE.

Nat Med. 2006 Jul;12(7):824-8.

PMID:
16767099
18.

Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice.

Savonenko AV, Melnikova T, Laird FM, Stewart KA, Price DL, Wong PC.

Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5585-90. doi: 10.1073/pnas.0710373105.

19.

Neuregulin 1 and schizophrenia.

Stefansson H, Steinthorsdottir V, Thorgeirsson TE, Gulcher JR, Stefansson K.

Ann Med. 2004;36(1):62-71. Review.

PMID:
15000348
20.

Neurobehavioral effects of delta 9-THC and cannabinoid (CB1) receptor gene expression in mice.

Onaivi ES, Chakrabarti A, Gwebu ET, Chaudhuri G.

Behav Brain Res. 1995 Dec 14;72(1-2):115-25.

PMID:
8788864
Items per page

Supplemental Content

Support Center